Aurobindo Pharma Ltd. | AUROPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
30,608
32,412
30,914
37,430
73,436
Cash flow Operating Act...
Cash flow Operating Activities
32,78619,54816,22043,81333,289
Investments in PPE
Investments in PPE
-16,942-15,299-14,257-13,828-18,738
Cash flow Investing Act...
Net cash used for Investment Activities
-17,870-19,570-28,768-15,6765,987
Dividend Paid
Dividend Paid
1,3722,6411,5991,8842,343
Cash flow Financing Act...
Net cash provided by Financing Activities
-19,1538,64219,191-19,472-13,648
Cash at beginning of period
Cash at beginning of period
7,4353,19612,09918,75627,468
Cash at end of period
Cash at end of period
3,19612,11818,75627,46853,299
Free Cash Flow
Free Cash Flow
15,844
4,249
1,964
29,985
14,551